Allison Bratzel, CFA

Allison Bratzel is a vice president and senior research analyst at Piper Sandler covering the biotechnology sector. Prior to joining Piper Sandler in 2017, she worked as an associate covering biotechnology at Raymond James and Robert W. Baird. She graduated from Michigan State University with degrees in finance and economics and is a CFA Charterholder.

Universe Coverage

Biotechnology
ABCL	AbCellera Biologics, Inc.
ABVX	Abivax SA
AKBA	Akebia Therapeutics, Inc.
ALXO	ALX Oncology Holdings, Inc.
ARGX	argenx SE
BHVN	Biohaven Ltd.
BMRN	BioMarin Pharmaceutical Inc.
CDXS	Codexis, Inc.
COGT	Cogent Biosciences, Inc.
ENGN	enGene Holdings, Inc.
HUMA	Humacyte, Inc.
IMRX	Immuneering Corp.
INCY	Incyte Corporation
IONS	Ionis Pharmaceuticals, Inc.
REPL	Replimune Group, Inc.
RIGL	Rigel Pharmaceuticals
ROIV	Roivant Sciences Ltd.
SRRK	Scholar Rock Holding Corp.
TVTX	Travere Therapeutics, Inc.
TYRA	Tyra Biosciences, Inc.
RARE	Ultragenyx Pharmaceutical, Inc.